PRIMARY HYPOGONADISM

PRIMARY HYPOGONADISM was reported 157 times

PRIMARY HYPOGONADISM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 2 0.0009
1 Topoisomerase Inhibitor [EPC] 34 0.0004
2 Recombinant Human Growth Hormone [EPC] 8 0.0004
3 Alkylating Drug [EPC] 72 0.0003
4 Progesterone [EPC] 6 0.0003
5 Androgen [EPC] 6 0.0002
6 Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] 1 0.0002
7 Lipid-based Polyene Antifungal [EPC] 2 0.0002
8 Bile Acid [EPC] 3 0.0001
9 5-alpha Reductase Inhibitor [EPC] 11 0.0001
10 Iron Chelator [EPC] 3 0.0001
11 Anticholinergic [EPC] 1 0.0001
12 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
13 Polyene Antifungal [EPC] 2 0.0000
14 Nucleoside Metabolic Inhibitor [EPC] 12 0.0000
15 Programmed Death Receptor-1 Blocking Antibody [EPC] 4 0.0000
16 Platinum-based Drug [EPC] 11 0.0000
17 Leukotriene Receptor Antagonist [EPC] 1 0.0000
18 Provitamin D2 Compound [EPC] 1 0.0000
19 Dietary Cholesterol Absorption Inhibitor [EPC] 3 0.0000
20 Folate Analog Metabolic Inhibitor [EPC] 14 0.0000
21 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0000
22 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
23 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
24 Protease Inhibitor [EPC] 1 0.0000
25 Insulin [EPC] 1 0.0000
26 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
27 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
28 Retinoid [EPC] 5 0.0000
29 Aminosalicylate [EPC] 2 0.0000
30 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1 0.0000
31 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
32 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
33 Methylxanthine [EPC] 1 0.0000
34 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
35 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
36 Expectorant [EPC] 3 0.0000
37 Tetracycline-class Drug [EPC] 1 0.0000
38 Leukocyte Growth Factor [EPC] 2 0.0000
39 Azole Antifungal [EPC] 2 0.0000
40 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
41 Nucleoside Analog Antiviral [EPC] 1 0.0000
42 Anti-IgE [EPC] 1 0.0000
43 RANK Ligand Inhibitor [EPC] 2 0.0000
44 Aromatase Inhibitor [EPC] 1 0.0000
45 Sulfonylurea [EPC] 1 0.0000
46 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
47 Aldosterone Antagonist [EPC] 1 0.0000
48 Janus Kinase Inhibitor [EPC] 1 0.0000
49 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
50 Microtubule Inhibitor [EPC] 1 0.0000
51 Corticosteroid [EPC] 7 0.0000
52 Estrogen [EPC] 1 0.0000
53 Platelet Aggregation Inhibitor [EPC] 3 0.0000
54 Interferon beta [EPC] 1 0.0000
55 Thiazide Diuretic [EPC] 1 0.0000
56 Vitamin C [EPC] 2 0.0000
57 GLP-1 Receptor Agonist [EPC] 2 0.0000
58 Insulin Analog [EPC] 2 0.0000
59 Loop Diuretic [EPC] 2 0.0000
60 Benzodiazepine [EPC] 3 0.0000
61 Opioid Agonist [EPC] 1 0.0000
62 Kinase Inhibitor [EPC] 2 0.0000
63 Vitamin D [EPC] 1 0.0000
64 beta-Adrenergic Blocker [EPC] 1 0.0000
65 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
66 Vitamin B12 [EPC] 1 0.0000
67 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
68 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
69 Atypical Antipsychotic [EPC] 1 0.0000
70 Thalidomide Analog [EPC] 1 0.0000
71 Tumor Necrosis Factor Blocker [EPC] 1 0.0000